<DOC>
	<DOCNO>NCT00991692</DOCNO>
	<brief_summary>A multisite trial test different dosage level systematic form Pediatric Constraint-Induced ( CI ) Therapy call ACQUIREc Therapy . The high dosage treatment involve 6 hour daily therapy service 21 day . This compare moderate dosage level 3 hour daily therapy service 21 day . It hypothesize child receive high therapy dosage would great clinically significant benefit ACQUIREc Therapy group child would benefit therapy service .</brief_summary>
	<brief_title>A Multisite Trial ACQUIREc Therapy</brief_title>
	<detailed_description />
	<mesh_term>Cerebral Palsy</mesh_term>
	<criteria>Children 36 year age Hemiparetic CP No prior CI therapy treatments No Botox 6months</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>8 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Pediatric CI Therapy</keyword>
	<keyword>ACQUIREc Therapy</keyword>
	<keyword>Dosage</keyword>
	<keyword>Occupational Therapy</keyword>
	<keyword>Physical Therapy</keyword>
	<keyword>Cerebral Palsy</keyword>
	<keyword>Hemiparesis</keyword>
</DOC>